Flovent
Product Images NDC 54868-5637

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 54868-5637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

110 Mcg Label (5362)

Packaging label for FLOVENT HFA 110 MCG inhaler distributed by Physicians Total Care, Inc. It includes the NDC number 54868-5362-0, lot number 0000, and expiration date 01/00. The label notes manufacturing by Glaxo Smith Kline, Research Triangle NC 27709, and contains a barcode with the number 53620120000.*

FDA Label Image

220 Mcg Label (5637)

Label for FLOVENT HFA 220 MCG Inhaler distributed by Physicians Total Care, Inc., Tulsa OK 74146. Includes NDC 54868-5637-0, expiration date 01/00, manufactured by Glaxo Smith Kline, Research Triangle NC 27709, and a barcode with number 56370120000.*

FDA Label Image

44 Mcg Label (5995)

Packaging label of FLOVENT HFA 44MCG inhaler distributed by Physicians Total Care, Inc. The label includes the NDC number 54868-5995-0, lot number 0000, expiration date 01/60, and manufacturer Glaxo Smith Kline Research Triangle NC 27709. A barcode is also present at the bottom.*

FDA Label Image

Fluticasone Propionate Chemical Structure (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 01)

Chemical structure diagram of the active ingredient in FLOVENT HFA, showing the molecular arrangement and key functional groups typical of a corticosteroid compound.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Patients Aged ≥12 Years Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (study 1) (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 02)

A line graph comparing the percentage change from baseline in FEV1 over 12 weeks and at an endpoint between placebo and FLOVENT HFA 88 mcg twice daily groups. The x-axis shows time in weeks, and the y-axis shows percent change, illustrating greater improvement for the FLOVENT HFA group than placebo over time.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Patients Aged ≥12 Years Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (study 2) (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 03)

A line graph showing the percentage change in FEV1 from baseline over a 12-week period for four groups: placebo, FLOVENT HFA 88 mcg twice daily, FLOVENT HFA 220 mcg twice daily, and FLOVENT HFA 440 mcg twice daily. The vertical axis represents percentage change, and the horizontal axis shows weeks, ending with the study endpoint. The graph illustrates different response levels by dosage over time.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Patients Aged ≥12 Years Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 04)

A bar chart comparing the percentage of patients experiencing 100% reduction in dose and percentage of patients with an increase in dose across three groups: Placebo, FLOVENT HFA 440 mcg twice daily, and FLOVENT HFA 880 mcg twice daily. The chart shows higher dose reduction percentages for FLOVENT HFA groups compared to placebo, and higher dose increase percentages for placebo compared to FLOVENT HFA groups.*

FDA Label Image

Figure 1 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 05)

An instructional diagram illustrating the components of a FLOVENT HFA inhaler. Labeled parts include the metal canister, counter, strap, cap, plastic actuator, and mouthpiece. The diagram highlights the device's structure for user understanding.*

FDA Label Image

Figure 2 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 06)

An instructional illustration showing how to hold the inhaler in the mouthpiece-down position. The diagram labels the mouthpiece, strap, and cap while depicting a hand gripping the inhaler appropriately.*

FDA Label Image

Figure 3 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 07)

An instructional illustration showing the proper use of an inhaler. It depicts a person holding the inhaler close to their mouth with the mouthpiece inserted, and an arrow indicating to push down on the inhaler while breathing in.*

FDA Label Image

Figure 4 (Be5c94a2 7c20 46d0 8829 Ac332a1c4eed 08)

An instructional diagram showing a person using a cotton swab to clean the mouthpiece area of a FLOVENT HFA inhaler. The illustration emphasizes proper cleaning technique, including rotating the swab inside the inhaler mouthpiece.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.